All Stories

  1. MicroRNA in Multiple Myeloma - A Role in Pathogenesis and Prognostic Significance

    Article • Current Medicinal Chemistry, October 2021, Bentham Science Publishers

    Tadeusz Robak

  2. Clinical management of mantle cell lymphoma in the elderly

    Article • Expert Opinion on Pharmacotherapy, August 2019, Taylor & Francis

    Tadeusz Robak

  3. Moxetumomab pasudotox for the treatment of hairy cell leukemia

    Article • Expert Opinion on Biological Therapy, May 2019, Taylor & Francis

    Tadeusz Robak

  4. Venetoclax in the treatment of chronic lymphocytic leukemia

    Article • Expert Opinion on Drug Metabolism & Toxicology, April 2019, Taylor & Francis

    Anna Korycka-Wolowiec, Aleksandra Kubiak-Mlonka, Tadeusz Robak

  5. Mantle cell lymphoma: therapeutic options in transplant-ineligible patients

    Article • Leukemia & Lymphoma, April 2019, Taylor & Francis

    Tadeusz Robak

  6. Single-agent ibrutinib versus chemoimmunotherapy regimens for treatment-naïve patients with chronic lymphocytic leukemia: A cross-trial comparison of phase 3 studies

    Article • American Journal of Hematology, October 2018, Wiley

    Tadeusz Robak

  7. The efficacy of sapacitabine in treating patients with acute myeloid leukemia

    Article • Expert Opinion on Pharmacotherapy, September 2018, Taylor & Francis

    Prof Agnieszka Wierzbowska, Tadeusz Robak

  8. Glasdegib in combination with cytarabine and daunorubicin in patients with AML or high-risk MDS: Phase 2 study results

    Article • American Journal of Hematology, September 2018, Wiley

    Tadeusz Robak

  9. Bendamustine alone or with rituximab modifies expression of apoptosis-regulating genes and proteins of CLL cells, depending on IGVH mutational status

    Article • Leukemia & Lymphoma, September 2018, Taylor & Francis

    Anna Korycka-Wolowiec, Ewa Balcerczak, Tadeusz Robak

  10. Book review: Safety of Biologics Therapy

    Article • Biologics Targets and Therapy, January 2017, Dove Medical Press

    Tadeusz Robak

  11. Current and emerging monoclonal antibody treatments for chronic lymphocytic leukemia: state of the art

    Article • Expert Review of Hematology, September 2014, Taylor & Francis

    Tadeusz Robak

  12. The Current Status of Cladribine in the Treatment of Lymphoid and Myeloid Malignancies

    Article • October 2013, Bentham Science Publishers

    Tadeusz Robak